Investments News
From code to cures: Chai Discovery’s big AI bet
TechCrunch - 15-Dec-2025
OpenAI-backed Chai raises $130M to accelerate drug and antibody design with AI
Read more...Nanotech BCI breakthrough wins new funding
Longevity Technology - 11-Dec-2025
Subsense advances non-surgical BCI tech with new $10M to speed preclinical research
Read more...The surgeon who wants robots to democratize healthcare
Forbes - 05-Dec-2025
Robotics pioneer Fred Moll backs AI-powered machines to expand access to complex surgery worldwide
Read more...Can cleaning your blood be the next big longevity trend?
HIT Consultant - 03-Dec-2025
Startup bets on plasma exchange to tackle microplastics, toxins, and chronic inflammation
Read more...Junevity raises $20M to advance siRNA-based cellular reprogramming
Longevity Technology - 03-Dec-2025
siRNA therapy JUN_01 aims to reset metabolic tissues and improve long-term metabolic health
Read more...Circular Genomics raises $15M for early Alzheimer’s detection
Longevity Technology - 02-Dec-2025
Blood-based circRNA signatures aim to spot Alzheimer’s risk years before symptoms appear
Read more...AGC Biologics and Repair Bio unite to advance plaque-clearing mRNA treatment
Longevity Technology - 25-Nov-2025
The teams aim to create an mRNA therapy that breaks down toxic cholesterol inside artery cells
Read more...The young founder teaching big pharma a new way to reverse aging
LEVITY - 21-Nov-2025
Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
Read more...Unlocking longevity through smart diagnostics
Live Forever Club - 18-Nov-2025
New Hevolution–Nanobiosym deal accelerates AI-driven metabolic and ageing diagnostics
Read more...Rewriting disease: Scripta Therapeutics targets the cell’s master switches
Longevity Technology - 17-Nov-2025
Startup uses transcription factor mapping to find disease-modifying treatments for neurodegeneration
Read more...AbbVie ends 11-year Calico partnership focused on aging research
FierceBiotech - 12-Nov-2025
AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
Read more...Lab-grown cells could reduce the need for donor transplants
Longevity Technology - 12-Nov-2025
The company hopes to begin human testing in the next few years
Read more...Lilly expands $100M AI drug discovery deal with Insilico Medicine
Longevity Technology - 11-Nov-2025
Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Read more...Inbrain teams with Microsoft to advance AI-powered brain implants
FierceBiotech - 11-Nov-2025
Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
Read more...Chan and Zuckerberg shift philanthropy toward AI-driven biomedical research
Independent - 06-Nov-2025
Biohub will invest ~$1B a year to build AI-driven virtual cells and speed disease research
Read more...Synchron raises $200M to advance thought-controlled tech
MobiHealthNews - 06-Nov-2025
Funding accelerates Stentrode’s clinical progress and hands-free device control for paralysis
Read more...Roche taps Manifold Bio to cross the brain barrier
FierceBiotech - 03-Nov-2025
$2B deal aims to develop AI-guided shuttles to carry therapies across the blood-brain barrier
Read more...Cyclana Bio: redefining women’s health
Longevity Technology - 30-Oct-2025
Using menstrual fluid, Cyclana builds tissue models to tackle endometriosis and chronic inflammation
Read more...Mission raises $13.3m for Parkinson’s mitophagy drug
Longevity Technology - 27-Oct-2025
Cambridge biotech to trial USP30 inhibitor MTX325 to boost mitochondrial repair in Parkinson’s
Read more...OrganOx sold for $1.5bn after creating device that keeps donor livers alive longer
BGF - 25-Oct-2025
The deal shows how long-term backing can help medical ideas reach real patients
Read more...Accel backs longevity startup Generation Lab
Fortune - 23-Oct-2025
Startup aims to add 20 healthy years through advanced epigenetic age testing
Read more...Elevara raises $70M to tackle rheumatoid arthritis
Longevity Technology - 23-Oct-2025
Biotech startup Elevara aims to transform RA treatment with a non-immunosuppressive oral drug
Read more...Eli Lilly backs NewLimit’s $45m push toward cellular rejuvenation
Longevity Technology - 21-Oct-2025
NewLimit’s $45M raise advances youthful liver and immune cell restoration in preclinical studies
Read more...Pelage secures $120M to advance stem cell hair loss therapy
Longevity Technology - 17-Oct-2025
PP405 shows early promise in reactivating dormant hair follicles to restore growth
Read more...Takeda partners with Nabla Bio to speed up drug discovery using AI
FierceBiotech - 14-Oct-2025
Their goal is to make treatments faster, safer, and more effective
Read more...Biotech’s comeback looks built to last
The Wall Street Journal - 13-Oct-2025
Easing regulations and new drug approvals fuel optimism for a sustained biotech rally
Read more...Kneu Health created an AI-powered phone app to detect early signs of brain decline
Longevity Technology - 09-Oct-2025
Trials showed fewer hospital visits and faster access to care
Read more...The Cat Health Company raises $1.2m to extend feline healthspan
Longevity Technology - 08-Oct-2025
Interim trials show improved weight, muscle, and vitality in aging cats with TCHC therapies
Read more...AI meets CRISPR: Algen and AstraZeneca join forces in $555m gene discovery deal
Longevity Technology - 06-Oct-2025
Partnership aims to uncover disease-driving genes and boost precision drug development
Read more...Gene therapy startup aims to reverse retinal aging to restore vision
Longevity Technology - 03-Oct-2025
Cirrus Therapeutics targets aging biology to combat blindness from dry AMD
Read more...Until Labs raises $58M to push boundaries of cryopreservation
Longevity Technology - 23-Sep-2025
Startup scaled cryopreservation from neural slices to large-animal organs, eyeing human trials
Read more...Oura ring maker secures $875M, valued at nearly $11B
TechCrunch - 22-Sep-2025
Oura doubles valuation to $10.9B after selling 5.5M rings and projecting $1B+ revenue in 2025
Read more...Bio Protocol raises $6.9M to scale AI-native DeSci biotech platform
Longevity Technology - 19-Sep-2025
First BioAgent generated 1,000+ hypotheses, raised $900K, and drove lab testing within weeks
Read more...Lila Sciences raises funds to grow AI labs that run experiments on their own
FierceBiotech - 15-Sep-2025
The funding will help expand facilities in Boston, San Francisco and London
Read more...Revalia Bio raises $14.5M to advance human organ-based drug testing
Longevity Technology - 09-Sep-2025
Using donated organs, Revalia aims to cut drug failures and speed safe treatments to patients
Read more...Ronovo secures $67M to expand modular robotic surgery platform
FierceBiotech - 09-Sep-2025
Backed by J&J, Carina robot gains traction in China with global approvals on the horizon
Read more...NRG raises $67M for mitochondrial drugs in neurodegeneration
Longevity Technology - 08-Sep-2025
Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons
Read more...Early investors squeezed out in longevity biotech funding deals
Fight Aging! - 03-Sep-2025
New funding terms cut early stakes by up to 100-to-1, threatening trust in longevity biotech
Read more...Novartis, Arrowhead sign $2b deal for Parkinson’s RNA therapy
Longevity Technology - 02-Sep-2025
Experimental RNAi drug aims to silence alpha-synuclein and slow neurodegeneration
Read more...Minovia powers up mitochondrial medicine
Longevity Technology - 01-Sep-2025
$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Read more...Debut raises $20M to pioneer AI-driven skin longevity ingredients
Longevity Technology - 28-Aug-2025
Startup uses AI to explore billions of molecules for next-gen skincare innovation
Read more...Aubrai launches to fund longevity science with AI and blockchain
CoinDesk - 25-Aug-2025
New DeSci platform uses tokens and AI to speed breakthroughs in ageing research
Read more...Genentech ends $2b cancer cell therapy pact with Adaptive
FierceBiotech - 18-Aug-2025
Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
Read more...VentriJect raises funds to expand quick no-exercise fitness test
EU-Startups - 12-Aug-2025
The device may help people track their health more easily and earlier in life
Read more...OneSkin raises $20M to boost skin longevity science
Longevity Technology - 08-Aug-2025
New funding will help expand OneSkin’s reach and target ageing at the cellular level
Read more...Chai Discovery secures $70m to accelerate AI-driven protein design
Endpoints News - 06-Aug-2025
Biotech startup’s valuation soars as it advances de novo protein generation with AI models.
Read more...Sava raises $19m for next-gen glucose monitoring wearable
Longevity Technology - 31-Jul-2025
With $19 million funding, the startup plans regulatory approvals and scaling
Read more...Immortal Dragons has launched with $40 million to support longevity research
Longevity Technology - 18-Jul-2025
The fund bridges East-West collaboration and acts quickly using its own capital
Read more...Synchron challenges Neuralink with minimally invasive brain implant
PC MAG - 16-Jul-2025
Stentrode lets users control devices with thoughts—implanted via blood vessels, not surgery
Read more...Mito Fund invests in Pretzel Therapeutics for mitochondrial disease therapies
Longevity Technology - 15-Jul-2025
New investment fuels development of therapies targeting mtDNA-related energy disorders
Read more...AgeCurve’s new patent tracks cell aging using mutations
AgeCurve - 10-Jul-2025
This can help doctors create better health tests and treatments
Read more...ScienceMachine raises 2.9m to accelerate biotech with AI
EU-Startups - 09-Jul-2025
AI startup ScienceMachine speeds up drug discovery by automating complex biotech data analysis
Read more...Chugai, Gero ink $250m deal to target ageing
FierceBiotech - 07-Jul-2025
Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
Read more...Epigenica debuts scalable tech to track epigenetic ageing
Longevity Technology - 04-Jul-2025
Epigenica launches scalable tech to decode epigenetic ageing and disease markers
Read more...China’s brain chips break new ground
Nature - 04-Jul-2025
BCIs in China help paralysed users control devices, play games, and speak Mandarin in real time
Read more...DNA reborn: engineering life from scratch
BBC - 26-Jun-2025
UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns
Read more...Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jun-2025
Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Read more...Outsee raises 1.8m for AI genomics in drug discovery
Longevity Technology - 25-Jun-2025
Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Read more...Infinity Bio raises $8m to decode the antibody reactome
Longevity Technology - 24-Jun-2025
Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
Read more...Robot surgeons for eyes: ForSight aims to revolutionize cataract surgery
Forbes - 24-Jun-2025
ForSight’s $125M boost powers eye-surgery robot tested in 300 pig-eye trials, human ops next
Read more...Cidara’s new flu drug shows strong protection in adults
BioPharma Dive - 23-Jun-2025
It may be a potential one-time seasonal alternative to vaccines without serious side effects
Read more...Parallel Bio raises $21m to replace animal testing with human immune organoids
Longevity Technology - 17-Jun-2025
New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models
Read more...Robotic puppy aims to bring comfort to people with dementia
MobiHealthNews - 13-Jun-2025
Earlier research shows many seniors feel calmer and happier with robotic pets
Read more...Juvena strikes $650m deal with lilly to tackle obesity
Longevity Technology - 11-Jun-2025
AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss
Read more...Splicebio raises $135m to advance gene therapy for eye disease
FierceBiotech - 11-Jun-2025
SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech
Read more...University spin-out Astratus unveils breakthrough in antibiotic testing
University of Reading - 10-Jun-2025
New tech delivers same-day results to improve prescriptions and curb rising antimicrobial resistance
Read more...AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition
Longevity Technology - 05-Jun-2025
Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
Read more...AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost
Longevity Technology - 30-May-2025
Biotech firm uses AI and robotics to test drugs on real human tissues, not animals
Read more...Magnitude Biosciences secures funding to boost AI-powered drug discovery
BusinessLive - 29-May-2025
Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies
Read more...Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025
The company is still in early stages but attracting strong investor interest
Read more...Maxwell’s AI platform drives revenue growth through health innovation
Live Forever Club - 27-May-2025
India partnerships and FDA progress boost future income
Read more...Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials
FierceBiotech - 27-May-2025
Biotech pivots to drug combo after monotherapy safety and efficacy setbacks
Read more...Starfish neuroscience unveils plans for tiny, wireless brain chip
The Verge - 24-May-2025
Valve CEO’s BCI firm builds battery-free chip to interact with multiple brain regions
Read more...Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025
Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
Read more...Tomorrow.Bio raises 5m to bring cryonics and life-after-death hopes to the U.S.
EU-Startups - 22-May-2025
Berlin startup freezes bodies, hoping for future revival
Read more...UK biotech Juvenescence secures over $150m to develop therapies
Endpoints News - 21-May-2025
Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases
Read more...Biostate AI raises $12M to boost RNA sequencing
HIT Consultant - 20-May-2025
New AI approach makes RNA sequencing cheaper and faster for disease prediction
Read more...23andMe’s fall from fame ends in Regeneron takeover
BBC - 19-May-2025
Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery
Read more...AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025
Somite AI uses DeltaStem to speed up and scale stem cell engineering
Read more...The billionaire blind spot: why longevity science is being overlooked
NFX - 15-May-2025
Unlocking ageing science could add decades of life—but funding is the missing link
Read more...From war zone to wellness: ukraine’s bold step into longevity science
Longevity Technology - 14-May-2025
Ukrainian scientists develop low-cost stem cell therapy now repurposed for healthy aging
Read more...BrightFocus Foundation fuels early research on aging diseases with $13m grants
Longevity Technology - 13-May-2025
Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma
Read more...Rewriting the cell's code: HAYA’s mission to transform genomic medicine
Longevity Technology - 12-May-2025
Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states
Read more...Xprize longevity contest narrows field to 40 semi-finalists
The Guardian - 11-May-2025
Drawn from over 1,000 global contenders, the selected teams are one step closer to the $101M prize
Read more...Hundred health acquires BellSant to supercharge AI longevity platform strapline:
Longevity Technology - 08-May-2025
AI-driven health platform gears up for launch with cutting-edge longevity data
Read more...Lilly bets big on AI-discovered ALS drug in $415m deal
FierceBiotech - 06-May-2025
AI-powered therapy offers new hope for ALS as early trials approach
Read more...NewLimit secures $130m to accelerate epigenetic reprogramming for longevity
Longevity Technology - 06-May-2025
The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan
Read more...Biotech shake-up: Unity and Mammoth announce major layoffs amid strategic shifts
FierceBiotech - 05-May-2025
Unity exits eye drug race, Mammoth tightens focus on CRISPR pipeline
Read more...Recursion overhauls pipeline after key drug fails in mid-stage trial
Endpoints News - 05-May-2025
With $509M in cash, biotech bets on fewer, stronger programs ahead of 2025 data
Read more...Stately Bio emerges with AI-powered window into living cells
Endpoints News - 01-May-2025
AI startup decodes live cell behaviour using simple imaging and machine learning
Read more...A brighter path for Parkinson’s: light therapy device nears FDA finish line
Longevity Technology - 28-Apr-2025
PhotoPharmics secures $6 million to advance its home-based Celeste device
Read more...Catalytic antibodies lose their champion
Fight Aging! - 23-Apr-2025
Covalent Biosciences falters amid investor caution, patent expiry, and steep development costs
Read more...Biolinq secures $100m to launch needle-free glucose monitor
FierceBiotech - 22-Apr-2025
Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
Read more...Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025
HepaRegeniX advances trials for a novel liver regeneration therapy
Read more...AI alliance to redefine the future of ageing and therapeutics
Juvenescence - 16-Apr-2025
M42 and Juvenescence join forces to accelerate precision medicine and longevity
Read more...Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025
A next-gen retinal implant offers new hope for vision loss from macular degeneration
Read more...Switching genes, not sequences: the rise of epigenetic editing
Chemistry World - 09-Apr-2025
Precision drugs use chemical tags to control genes without changing DNA
Read more...New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025
It avoids common delivery problems and enters Phase 1 trials in 2025
Read more...China’s RiboX beats rivals to launch first circular RNA clinical trial
Endpoints News - 04-Apr-2025
A stealthy Shanghai startup pioneers a longer-lasting, safer alternative to mRNA and gene therapies
Read more...Isomorphic Labs secures $600m to supercharge AI drug discovery
FierceBiotech - 31-Mar-2025
Backed by Nobel science, the Alphabet spinout speeds up AI drug development
Read more...
